Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Transplantation

• Publication date

  2002-11-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200211270-00004PMID 12451233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models.

  2001cited by this paper
• Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

  2001cited by this paper
• Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.

  2001cited by this paper
• Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

  2001cited by this paper
• FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.

  2001cited by this paper
• FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation.

  2000cited by this paper
• Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model.

  2000cited by this paper
• FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1

  2000cited by this paper
• The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.

  2000cited by this paper
• Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.

  1999cited by this paper
• Pharmacokinetics Of Erl080a: A New Enteric Coated Formulation Of Mycophenolic Acid-sodium

  1999cited by this paper
• Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.

  1999cited by this paper
• FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.

  1999cited by this paper
• Mycophenolate mofetil: a review of its use in the management of solid organ transplantation.

  1999cited by this paper
• FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.

  1998cited by this paper
• FTY720: a new immunosuppressive agent with novel mechanism(s) of action.

  1998cited by this paper
• Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.

  1998cited by this paper
• FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.

  1998cited by this paper
• FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.

  1996cited by this paper
• The effect of a nonsteroid immunosuppressive regimen with RS-61443 and cyclosporine on kidney allograft survival in dogs.

  1996cited by this paper
• Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat.

  1996cited by this paper
• Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone.

  1993cited by this paper
• Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.

  1992cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.

  1990cited by this paper
• The role of de novo purine synthesis in lymphocyte transformation.

  1977cited by this paper
• Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.

  1975cited by this paper
• Metabolism and biochemistry of mycophenolic acid.

  1972cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Protein Kinase C Inhibition Ameliorates Posttransplantation Preservation Injury in Rat Renal Transplants

  2012cites this paper
• Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats

  2007cites this paper
• A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site.

  2006cites this paper
• Use of Sphingosine-1-Phosphate 1 Receptor Agonist, KRP-203, in Combination with a Subtherapeutic Dose of Cyclosporine A for Rat Renal Transplantation

  2006cites this paper
• Fingolimod. Mitsubishi Pharma/Novartis.

  2005cites this paper
• Enteric-coated mycophenolate sodium - current and future use in transplant patients

  2005cites this paper
• Review of the immunosuppressant enteric-coated mycophenolate sodium

  2004cites this paper
• Role of the microenvironment in immune responses to transplantation

  2003cites this paper